Published Research | March 2021

February 2021 Papers | All 2020 Published Papers by Month

March 30, 2021

  1. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – Lancet
  2. The emerging plasticity of SARS-CoV-2 – Science
  3. Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 – CDC MMWR

March 25, 2021

  1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – Journal of Medical Microbiology

March 24, 2021

  1. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California – NEJM
  2. Post-acute COVID-19 syndrome – Nature

March 17, 2021

  1. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 – Nature
  2. Age and Likelihood of Symptoms and Critical Disease After SARS-CoV-2 – American College of Cardiology

March 15, 2021

  1. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 – Nature

March 11, 2021

  1. Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening – Clinical Infectious Diseases

March 10, 2021

  1. Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern – The Lancet
  2. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine – NEJM
  3. SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States – JAMA
  4. Brazil’s COVID-19 Cases Rise Amid Disinformation, Variant P.1 – NPR

March 9, 2021

  1. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike – PNAS
  2. Identification of human immune cell subtypes most responsive to IL-1β–induced inflammatory signaling using mass cytometry – Science
  3. SARS-CoV-2: an occupational hazard presenting challenges for low- and middle-income countries – Environmental Health
  4. School-Related SARS-CoV-2 Transmission: Modes and Mitigations – NEJM

March 8, 2021

  1. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis – The Lancet
  2. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 – Nature
  3. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 – Nature
  4. Familial Clustering and Re-infection with 2019 Novel Coronavirus (2019-nCoV, SARS-CoV-2) in the Libyan Community – CambridgeCore

March 4, 2021

  1. A neutrophil activation signature predicts critical illness and mortality in COVID-19 – Blood Advances
  2. Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19 – Nature
  3. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England – Science

March 3, 2021

  1. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients – Frontiers in Immunology
  2. Comparison of Respiratory Specimens for the Detection of SARS-CoV-2 – Annals of Clinical and Laboratory Science
  3. Immunoreactive peptide maps of SARS-CoV-2 – Nature

March 2, 2021

  1. Bepridil is potent against SARS-CoV-2 in vitro – PNAS
February 2021 Papers | All 2020 Published Papers by Month